Gene: CALHM2
Official Full Name: calcium homeostasis modulator family member 2provided by HGNC
Gene Summary: Predicted to enable monoatomic cation channel activity. Involved in ATP export and positive regulation of apoptotic process. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06334 | CALHM2 Knockout cell line (HeLa) | Human | CALHM2 | 1:3~1:6 | Negative | Online Inquiry |
KO06335 | CALHM2 Knockout cell line (HCT 116) | Human | CALHM2 | 1:2~1:4 | Negative | Online Inquiry |
KO06336 | CALHM2 Knockout cell line (HEK293) | Human | CALHM2 | 1:3~1:6 | Negative | Online Inquiry |
KO06337 | CALHM2 Knockout cell line (A549) | Human | CALHM2 | 1:3~1:4 | Negative | Online Inquiry |
CALHM2 Gene Knockout Cell Lines are precisely engineered cellular models that have undergone targeted deletion of the CALHM2 gene, which encodes a protein involved in cellular signaling and calcium homeostasis. These knockout cell lines serve as vital tools for understanding the role of CALHM2 in various biological processes, particularly its implications in neurodegenerative diseases and synaptic transmission.
The primary function of CALHM2 is to facilitate calcium ion transport across the cellular membrane, influencing neurotransmitter release and neuronal excitability. By creating a knockout model, researchers can dissect the molecular mechanisms underpinning calcium signaling and assess the downstream effects on neuronal function and health. The ability to observe these alterations in a controlled cellular environment allows for more nuanced investigations into disorders such as Alzheimer's disease and other forms of dementia, providing insights into potential therapeutic targets.
From a scientific perspective, the implications of CALHM2 gene knockout extend into both basic and applied research. They allow for elucidation of the pathways involved in calcium dysregulation and contribute to the development of pharmacological interventions aimed at modulating these pathways. Additionally, the application of these models in high-throughput screening can accelerate drug discovery processes.
Compared to alternatives such as wild-type cell lines or less specific gene-editing techniques, CALHM2 Gene Knockout Cell Lines provide a unique advantage by focusing specifically on this gene's function while maintaining genetic integrity beyond the knockout site. This specificity minimizes off-target effects and enhances the reliability of experimental outcomes, making it easier for researchers to draw conclusions from their data.
Researchers and clinicians seeking to advance their understanding of calcium signaling will find CALHM2 Gene Knockout Cell Lines invaluable in pushing the boundaries of knowledge. Their utility in both novel research avenues and translational applications underscores their importance in the ongoing quest to unravel complex biological systems.
At [Your Company Name], we specialize in developing innovative biological tools, and our expertise in gene editing technology ensures that our CALHM2 Gene Knockout Cell Lines are of the highest quality and reliability. By providing premier research solutions, we empower scientists and clinicians to achieve their objectives in understanding health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.